Abstract 2335P
Background
In invasive lung adenocarcinoma (LUAD), patients with micropapillary (MIP) or solid (SOL) components had a significantly poorer prognosis than those with only lepidic (LEP), acinar (ACI) or papillary (PAP) components. It is interesting to explore the genetic features of different histologic subtypes especially the highly aggressive components.
Methods
This study comprised four cohorts of patients who underwent complete surgical resection for lung adenocarcinoma (LUAD) and had their medical records reviewed. Cohort 1 depicted the distribution of different histological subtypes across tumor size groups. Logistic regression analysis in cohort 2 investigated the associations between driver mutations and histological subtypes. Cohort 3 utilized spatial whole-exome sequencing with laser-capture microdissection to identify genetic heterogeneity among histological components within the same tumor. Cohort 4, in conjunction with the cBioportal cohort, was employed to validate the findings obtained from cohort 3.
Results
Based on a cohort of 5,933 patients (cohort 1), this study observed varying prevalence of micropapillary (MIP) and solid (SOL) components in different tumor size groups. Furthermore, cohort 2 revealed that patients with ALK fusion or TP53 mutations had a higher probability of developing MIP/SOL components in cohort 2. To account for individual differences, tspatial whole-exome sequencing was performed using laser-capture microdissection on five patients with coexistent components, enabling the identification of genetic features within the same tumor. In tracing the evolution of components, we found that titin mutation might serve as a crucial intratumor potential driver for MIP/SOL components, which was validated by the cohort 4 of 146 LUAD patients undergoing bulk WES. Functional analysis demonstrated that TTN mutations were enriched the complement and coagulation cascades, which correlated with the pathway of cell adhesion, migration, and proliferation.
Conclusions
Collectively, the histologic subtypes of invasive LUAD were genetically different, and certain trunk genotypes might synergize with branching TTN mutation to develop highly aggressive components.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2347P - Correlation between second primary cancers and first primary cancers: A systematic review and meta-analysis of 9 million cancer patients
Presenter: Xinyu Wang
Session: Poster session 16
2348P - High-throughput screening reveals GSK1838705A as a potent inhibitor of CAFs-promoted tumor progression in esophageal squamous cell carcinoma
Presenter: hongfang zhang
Session: Poster session 16
2349P - Patterns and frequency of pathogenic germline variants (PGVs) among non-western young male patients with cancer: The Jordanian exploratory cancer genetics (Jo-ECAG) study
Presenter: Hira Bani Hani
Session: Poster session 16
2350P - Single-cell RNA-seq dissecting the initiating liver metastasis cells in various cancers
Presenter: Shu-yue Zheng
Session: Poster session 16
2351P - Whole genome sequencing of AYA patients
Presenter: Paul Roepman
Session: Poster session 16
2352P - Sex-based differences in genomic alterations and biomarkers in anal squamous cell carcinoma (ASCC)
Presenter: Stefano Cereda
Session: Poster session 16
2353P - Anti-cancer effects of HDAC8 specific inhibitors EC-352H and EC-374H in lymphoma
Presenter: So Young Lee
Session: Poster session 16
2354P - Computational pathology-derived features capture varied epithelial-mesenchymal transition (EMT) states
Presenter: Herbert Levine
Session: Poster session 16
2355P - Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors
Presenter: Kristina Jansen
Session: Poster session 16
2356P - The role of pathological features in predicting prognosis of patients with advanced RET-positive NSCLC
Presenter: Arianna Marinello
Session: Poster session 16